<p>Doximity, Inc.（紐約證券交易所代碼：DOCS - 獲取免費報告）在週四創下 52 周新低，此前一名內部人士出售了該公司的股票。該公司股價最低跌至 17.32 美元，最後交易價格為 17.8060 美元，成交量為 3,490,995 股。該股票此前收盤價為 23.39 美元。</p>
<ul>
<li>Doximity 是醫療社區的 Facebook 和 LinkedIn</li>
</ul>
<p>具體來説，內部人士 Siddharth Sitaram 在 5 月 11 日（星期一）出售了 2,309 股該公司的股票，交易平均價格為 25.77 美元，總交易額為 59,502.93 美元。交易完成後，該內部人士直接持有 89,396 股公司股票，價值為 2,303,734.92 美元。這筆交易代表其持股比例減少了 2.52%。該出售在與證券交易委員會的法律文件中披露，相關信息可通過 SEC 網站獲取。該交易是在預先安排的 10b5-1 交易計劃下執行的。出售是為了覆蓋與股權獎勵歸屬相關的税收扣繳義務。此外，董事 Kira Scherer Wampler 在 5 月 7 日（星期四）出售了 9,000 股該公司的股票，交易平均價格為 26.06 美元，總交易額為 234,540.00 美元。出售後，該董事持有 19,839 股公司股票，價值約為 517,004.34 美元。這代表其持股比例減少了 31.21%。該出售的 SEC 文件提供了更多信息。該交易是在預先安排的 10b5-1 交易計劃下執行的。</p>
<h2>華爾街分析師觀點</h2>
<p>多位分析師對該公司發表了評論。Canaccord Genuity Group 在 2 月 9 日（星期一）對 Doximity 設定了 34.00 美元的目標價，並給予該股票 “買入” 評級。摩根士丹利將 Doximity 的目標價從 49.00 美元下調至 35.00 美元，並在週四的報告中對該公司設定了 “增持” 評級。KeyCorp 在週四的研究報告中將 Doximity 的評級從 “增持” 下調至 “行業權重”。BMO 資本市場在週四的研究報告中將 Doximity 的目標價從 25.00 美元下調至 20.00 美元，並對該公司設定了 “市場表現” 評級。最後，Robert W. Baird 在週四的研究報告中重申了 “中性” 評級，並將 Doximity 的目標價設定為 18.00 美元（低於 40.00 美元）。兩位股票研究分析師對該股票給予了強烈買入評級，八位給予了買入評級，十三位給予了持有評級。根據 MarketBeat.com 的數據，該股票的平均評級為 “適度買入”，平均目標價為 32.38 美元。</p>
<ul>
<li>Doximity 是一個被忽視的醫療生態系統 AI 投資</li>
</ul>
<p><strong>查看我們最新的 DOCS 股票分析</strong></p>
<h2>更多 Doximity 新聞</h2>
<p>以下是本週影響 Doximity 的主要新聞：</p>
<ul>
<li>積極情緒：Doximity 報告調整後的每股收益為 0.26 美元，超過了一位分析師的預期，收入同比增長 5.1%，達到 1.4537 億美元，顯示出業務仍在增長。Doximity 財報</li>
<li>積極情緒：該公司強調了強勁的盈利能力，包括 37.54% 的淨利潤率和 23.84% 的股本回報率，支持其高利潤率的商業模式。2026 財年第四季度財報快照</li>
<li>中性情緒：內部人士 Siddharth Sitaram 出售了 2,309 股，但該交易是預先安排的 10b5-1 計劃的一部分，並與股權歸屬的税收扣繳相關，因此比自願出售的擔憂要小。內部人士出售披露</li>
<li>消極情緒：投資者關注 Doximity 未能達到更廣泛的盈利預期，EPS 為 0.26 美元，而 Zacks 共識為 0.28 美元，這表明本季度的表現不如頭條結果所暗示的那樣強勁。Doximity 未能達到 2026 財年第四季度盈利預期</li>
<li>消極情緒：更重要的是，管理層對 2027 財年和 2027 財年第一季度的收入指引低於華爾街預期，引發了對增長放緩和與 AI 投資相關的支出增加的擔憂。Doximity 2026 財年第四季度電話會議記錄</li>
<li>消極情緒：經紀公司也變得更加謹慎，BMO 資本市場將其目標價下調至 20 美元，瑞穗將其目標價下調至 26 美元，進一步強化了對該股票的弱勢情緒。分析師目標價變動</li>
</ul>
<h2>Doximity 價格表現</h2>
<ul>
<li>Doximity 股票是一個有趣的醫療投資</li>
</ul>
<p>該公司的市值為 32.8 億美元，市盈率為 14.84，市盈增長比率為 1.88，貝塔值為 1.36。該股票的 50 日簡單移動平均線為 24.27 美元。</p>
<p>Doximity 宣佈其董事會已於 2 月 5 日（星期四）批准了一項股票回購計劃，授權公司回購 5 億美元的流通股。該回購授權允許公司通過公開市場購買最多 8% 的股份。股票回購計劃通常表明公司領導層認為其股票被低估。</p>
<h2>機構資金流入和流出</h2>
<p>一些大型投資者最近對 DOCS 的持倉進行了調整。加拿大皇家銀行在第一季度將其在 Doximity 的持股增加了 24.2%。加拿大皇家銀行目前擁有 106,845 股該公司的股票，價值 6,200,000 美元，此前在上個季度又購買了 20,847 股。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第一季度將其在 Doximity 的持倉提高了 0.5%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.目前擁有 38,978 股該公司的股票，價值 2,262,000 美元，此前在上個季度又購買了 210 股。NewEdge Advisors LLC 在第一季度將其在 Doximity 的持股增加了 613.7%。NewEdge Advisors LLC 目前擁有 6,323 股該公司的股票，價值 367,000 美元，此前在上個季度又購買了 5,437 股。高盛集團在第一季度將其在 Doximity 的持股增加了 33.3%。高盛集團目前擁有 255,529 股該公司的股票，價值 14,828,000 美元，此前在上個季度又購買了 63,873 股。最後，Focus Partners Wealth 在第一季度購買了 Doximity 的新持倉，價值 283,000 美元。87.19% 的股票由對沖基金和其他機構投資者持有。</p>
<h2>Doximity 公司簡介</h2>
<p>(獲取免費報告)</p>
<p>Doximity 以 DOCS 的名義運營，是一個數字專業網絡和通信平台，主要為臨牀醫生設計。公司總部位於舊金山，連接醫生、護士執業者、醫師助理和其他醫療專業人員，提供簡化臨牀溝通、遠程醫療交付和獲取專業特定醫療信息的工具。其平台被定位為一個專業中心，臨牀醫生可以在此管理工作流程、跟進醫學新聞並與同行安全協作。</p>
<p>該公司的產品包括安全消息傳遞和視頻遠程醫療功能，使臨牀醫生能夠在保護患者信息的同時與患者和同事進行諮詢。</p>
<h2>精選故事</h2>
<ul>
<li>五隻我們更看好的股票，而不是 Doximity</li>
<li>eVTOL 投資：拋棄出租車，購買藍圖</li>
<li>伯克希爾的《紐約時報》投資現狀如何</li>
<li>Affirm 與谷歌的交易旨在爭取你的錢包</li>
<li>保持航班運行的飛機維修公司準備騰飛</li>
</ul>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Doximity 嗎？</h2>
<p>在考慮 Doximity 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Doximity 並不在名單上。</p>
<p>雖然 Doximity 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

DOCS

LGHT

HEAL

<p>Doximity（紐約證券交易所代碼：DOCS）在內部人士出售後，股價達到 52 周新低 17.32 美元，最後交易價格為 17.8060 美元。內部人士 Siddharth Sitaram 以 25.77 美元的價格出售了 2,309 股，而董事 Kira Scherer Wampler 以 26.06 美元的價格出售了 9,000 股。分析師們的看法不一，目標價格範圍從 18.00 美元到 34.00 美元不等。儘管報告了 5.1% 的收入增長，但公司未能達到盈利預期，並對 2027 財年的收入指引下調，引發了對增長的擔憂。Doximity 的董事會批准了一項 5 億美元的股票回購計劃，顯示出對股票價值的信心</p>

<p>Doximity, Inc. (NYSE:DOCS - Get Free Report)'s share price hit a new 52-week low on Thursday after an insider sold shares in the company. The company traded as low as $17.32 and last traded at $17.8060, with a volume of 3490995 shares traded. The stock had previously closed at $23.39.</p>
<div class="lb-trans"><p>Doximity, Inc.（紐約證券交易所代碼：DOCS - 獲取免費報告）在週四創下 52 周新低，此前一名內部人士出售了該公司的股票。該公司股價最低跌至 17.32 美元，最後交易價格為 17.8060 美元，成交量為 3,490,995 股。該股票此前收盤價為 23.39 美元。</p>
</div><ul>
<li>Doximity is the Facebook and LinkedIn of the Medical Community</li>
</ul>
<div class="lb-trans"><ul>
<li>Doximity 是醫療社區的 Facebook 和 LinkedIn</li>
</ul>
</div><p>Specifically, insider Siddharth Sitaram sold 2,309 shares of the firm's stock in a transaction on Monday, May 11th. The stock was sold at an average price of $25.77, for a total transaction of $59,502.93. Following the completion of the transaction, the insider directly owned 89,396 shares in the company, valued at $2,303,734.92. This trade represents a 2.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Kira Scherer Wampler sold 9,000 shares of the firm's stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $26.06, for a total transaction of $234,540.00. Following the sale, the director owned 19,839 shares of the company's stock, valued at approximately $517,004.34. This represents a 31.21% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.</p>
<div class="lb-trans"><p>具體來説，內部人士 Siddharth Sitaram 在 5 月 11 日（星期一）出售了 2,309 股該公司的股票，交易平均價格為 25.77 美元，總交易額為 59,502.93 美元。交易完成後，該內部人士直接持有 89,396 股公司股票，價值為 2,303,734.92 美元。這筆交易代表其持股比例減少了 2.52%。該出售在與證券交易委員會的法律文件中披露，相關信息可通過 SEC 網站獲取。該交易是在預先安排的 10b5-1 交易計劃下執行的。出售是為了覆蓋與股權獎勵歸屬相關的税收扣繳義務。此外，董事 Kira Scherer Wampler 在 5 月 7 日（星期四）出售了 9,000 股該公司的股票，交易平均價格為 26.06 美元，總交易額為 234,540.00 美元。出售後，該董事持有 19,839 股公司股票，價值約為 517,004.34 美元。這代表其持股比例減少了 31.21%。該出售的 SEC 文件提供了更多信息。該交易是在預先安排的 10b5-1 交易計劃下執行的。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>華爾街分析師觀點</h2>
</div><p>A number of analysts have commented on the company. Canaccord Genuity Group set a $34.00 target price on Doximity and gave the stock a &#34;buy&#34; rating in a report on Monday, February 9th. Morgan Stanley reduced their price objective on Doximity from $49.00 to $35.00 and set an &#34;overweight&#34; rating for the company in a report on Thursday. KeyCorp cut shares of Doximity from an &#34;overweight&#34; rating to a &#34;sector weight&#34; rating in a research note on Thursday. BMO Capital Markets reduced their price target on shares of Doximity from $25.00 to $20.00 and set a &#34;market perform&#34; rating for the company in a research note on Thursday. Finally, Robert W. Baird restated a &#34;neutral&#34; rating and set a $18.00 price objective (down from $40.00) on shares of Doximity in a research report on Thursday. Two equities research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and thirteen have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of &#34;Moderate Buy&#34; and an average price target of $32.38.</p>
<div class="lb-trans"><p>多位分析師對該公司發表了評論。Canaccord Genuity Group 在 2 月 9 日（星期一）對 Doximity 設定了 34.00 美元的目標價，並給予該股票 “買入” 評級。摩根士丹利將 Doximity 的目標價從 49.00 美元下調至 35.00 美元，並在週四的報告中對該公司設定了 “增持” 評級。KeyCorp 在週四的研究報告中將 Doximity 的評級從 “增持” 下調至 “行業權重”。BMO 資本市場在週四的研究報告中將 Doximity 的目標價從 25.00 美元下調至 20.00 美元，並對該公司設定了 “市場表現” 評級。最後，Robert W. Baird 在週四的研究報告中重申了 “中性” 評級，並將 Doximity 的目標價設定為 18.00 美元（低於 40.00 美元）。兩位股票研究分析師對該股票給予了強烈買入評級，八位給予了買入評級，十三位給予了持有評級。根據 MarketBeat.com 的數據，該股票的平均評級為 “適度買入”，平均目標價為 32.38 美元。</p>
</div><ul>
<li>Doximity is an Overlooked Medical Ecosystem AI Play</li>
</ul>
<div class="lb-trans"><ul>
<li>Doximity 是一個被忽視的醫療生態系統 AI 投資</li>
</ul>
</div><p><strong>View Our Latest Stock Analysis on DOCS</strong></p>
<div class="lb-trans"><p><strong>查看我們最新的 DOCS 股票分析</strong></p>
</div><h2>More Doximity News</h2>
<div class="lb-trans"><h2>更多 Doximity 新聞</h2>
</div><p>Here are the key news stories impacting Doximity this week:</p>
<div class="lb-trans"><p>以下是本週影響 Doximity 的主要新聞：</p>
</div><ul>
<li>Positive Sentiment: Doximity reported adjusted EPS of $0.26, topping one analyst estimate, and revenue rose 5.1% year over year to $145.37 million, showing the business is still growing. Doximity Earnings Report</li>
<li>Positive Sentiment: The company highlighted strong profitability, including a 37.54% net margin and 23.84% return on equity, which supports its high-margin business model. Fiscal Q4 Earnings Snapshot</li>
<li>Neutral Sentiment: Insider Siddharth Sitaram sold 2,309 shares, but the transaction was part of a pre-arranged 10b5-1 plan and tied to tax withholding from equity vesting, making it less concerning than a discretionary sale. Insider Sale Disclosure</li>
<li>Negative Sentiment: Investors focused on the fact that Doximity missed broader earnings expectations, with EPS of $0.26 versus the Zacks consensus of $0.28, which suggests the quarter was not as strong as headline results implied. Doximity Lags Q4 Earnings Estimates</li>
<li>Negative Sentiment: More importantly, management’s FY2027 and Q1 FY2027 revenue guidance came in below Wall Street estimates, fueling concerns about slowing growth and higher spending related to AI investments. Doximity Q4 2026 Earnings Call Transcript</li>
<li>Negative Sentiment: Brokerage firms also turned more cautious, with BMO Capital Markets cutting its price target to $20 and Mizuho lowering its target to $26, reinforcing the weaker sentiment around the stock. Analyst Price Target Changes</li>
</ul>
<div class="lb-trans"><ul>
<li>積極情緒：Doximity 報告調整後的每股收益為 0.26 美元，超過了一位分析師的預期，收入同比增長 5.1%，達到 1.4537 億美元，顯示出業務仍在增長。Doximity 財報</li>
<li>積極情緒：該公司強調了強勁的盈利能力，包括 37.54% 的淨利潤率和 23.84% 的股本回報率，支持其高利潤率的商業模式。2026 財年第四季度財報快照</li>
<li>中性情緒：內部人士 Siddharth Sitaram 出售了 2,309 股，但該交易是預先安排的 10b5-1 計劃的一部分，並與股權歸屬的税收扣繳相關，因此比自願出售的擔憂要小。內部人士出售披露</li>
<li>消極情緒：投資者關注 Doximity 未能達到更廣泛的盈利預期，EPS 為 0.26 美元，而 Zacks 共識為 0.28 美元，這表明本季度的表現不如頭條結果所暗示的那樣強勁。Doximity 未能達到 2026 財年第四季度盈利預期</li>
<li>消極情緒：更重要的是，管理層對 2027 財年和 2027 財年第一季度的收入指引低於華爾街預期，引發了對增長放緩和與 AI 投資相關的支出增加的擔憂。Doximity 2026 財年第四季度電話會議記錄</li>
<li>消極情緒：經紀公司也變得更加謹慎，BMO 資本市場將其目標價下調至 20 美元，瑞穗將其目標價下調至 26 美元，進一步強化了對該股票的弱勢情緒。分析師目標價變動</li>
</ul>
</div><h2>Doximity Price Performance</h2>
<div class="lb-trans"><h2>Doximity 價格表現</h2>
</div><ul>
<li>Doximity Stock is an Interesting Healthcare Play</li>
</ul>
<div class="lb-trans"><ul>
<li>Doximity 股票是一個有趣的醫療投資</li>
</ul>
</div><p>The company has a market capitalization of $3.28 billion, a P/E ratio of 14.84, a P/E/G ratio of 1.88 and a beta of 1.36. The stock has a fifty day simple moving average of $24.27.</p>
<div class="lb-trans"><p>該公司的市值為 32.8 億美元，市盈率為 14.84，市盈增長比率為 1.88，貝塔值為 1.36。該股票的 50 日簡單移動平均線為 24.27 美元。</p>
</div><p>Doximity declared that its board has approved a stock repurchase program on Thursday, February 5th that authorizes the company to repurchase $500.00 million in outstanding shares. This repurchase authorization authorizes the company to buy up to 8% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company's leadership believes its shares are undervalued.</p>
<div class="lb-trans"><p>Doximity 宣佈其董事會已於 2 月 5 日（星期四）批准了一項股票回購計劃，授權公司回購 5 億美元的流通股。該回購授權允許公司通過公開市場購買最多 8% 的股份。股票回購計劃通常表明公司領導層認為其股票被低估。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>機構資金流入和流出</h2>
</div><p>A number of large investors have recently made changes to their positions in DOCS. Royal Bank of Canada lifted its holdings in Doximity by 24.2% in the 1st quarter. Royal Bank of Canada now owns 106,845 shares of the company's stock worth $6,200,000 after purchasing an additional 20,847 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Doximity by 0.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 38,978 shares of the company's stock valued at $2,262,000 after buying an additional 210 shares during the last quarter. NewEdge Advisors LLC lifted its holdings in shares of Doximity by 613.7% in the first quarter. NewEdge Advisors LLC now owns 6,323 shares of the company's stock worth $367,000 after buying an additional 5,437 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in shares of Doximity by 33.3% in the first quarter. Goldman Sachs Group Inc. now owns 255,529 shares of the company's stock worth $14,828,000 after buying an additional 63,873 shares in the last quarter. Finally, Focus Partners Wealth bought a new position in shares of Doximity during the first quarter worth $283,000. 87.19% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>一些大型投資者最近對 DOCS 的持倉進行了調整。加拿大皇家銀行在第一季度將其在 Doximity 的持股增加了 24.2%。加拿大皇家銀行目前擁有 106,845 股該公司的股票，價值 6,200,000 美元，此前在上個季度又購買了 20,847 股。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第一季度將其在 Doximity 的持倉提高了 0.5%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.目前擁有 38,978 股該公司的股票，價值 2,262,000 美元，此前在上個季度又購買了 210 股。NewEdge Advisors LLC 在第一季度將其在 Doximity 的持股增加了 613.7%。NewEdge Advisors LLC 目前擁有 6,323 股該公司的股票，價值 367,000 美元，此前在上個季度又購買了 5,437 股。高盛集團在第一季度將其在 Doximity 的持股增加了 33.3%。高盛集團目前擁有 255,529 股該公司的股票，價值 14,828,000 美元，此前在上個季度又購買了 63,873 股。最後，Focus Partners Wealth 在第一季度購買了 Doximity 的新持倉，價值 283,000 美元。87.19% 的股票由對沖基金和其他機構投資者持有。</p>
</div><h2>Doximity Company Profile</h2>
<div class="lb-trans"><h2>Doximity 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(獲取免費報告)</p>
</div><p>Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.</p>
<div class="lb-trans"><p>Doximity 以 DOCS 的名義運營，是一個數字專業網絡和通信平台，主要為臨牀醫生設計。公司總部位於舊金山，連接醫生、護士執業者、醫師助理和其他醫療專業人員，提供簡化臨牀溝通、遠程醫療交付和獲取專業特定醫療信息的工具。其平台被定位為一個專業中心，臨牀醫生可以在此管理工作流程、跟進醫學新聞並與同行安全協作。</p>
</div><p>The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.</p>
<div class="lb-trans"><p>該公司的產品包括安全消息傳遞和視頻遠程醫療功能，使臨牀醫生能夠在保護患者信息的同時與患者和同事進行諮詢。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精選故事</h2>
</div><ul>
<li>Five stocks we like better than Doximity</li>
<li>eVTOL Investing: Ditch the Taxi, Buy the Blueprint</li>
<li>How Berkshire’s New York Times Bet Looks Today</li>
<li>Affirm's Google Deal Aims for Your Wallet</li>
<li>Airplane Maintenance Companies That Keep Flights Moving Are Ready to Soar</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，而不是 Doximity</li>
<li>eVTOL 投資：拋棄出租車，購買藍圖</li>
<li>伯克希爾的《紐約時報》投資現狀如何</li>
<li>Affirm 與谷歌的交易旨在爭取你的錢包</li>
<li>保持航班運行的飛機維修公司準備騰飛</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Doximity Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Doximity 嗎？</h2>
</div><p>Before you consider Doximity, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Doximity 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Doximity 並不在名單上。</p>
</div><p>While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Doximity 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Doximity (NYSE:DOCS) Sets New 52-Week Low After Insider Selling

Market Beat

Doximity

Langar Global HealthTech ETF

Global X HealthTech ETF

First Trust Nasdaq Lux Digital Health Solutions ETF

摩根士丹利

科凱國際

蒙特利爾銀行

瑞穗金融集團

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

KEYCORP DEP SHS REP 1/40TH NON CUM PER PFD SER G

KEYCORP DEP SHS REPSTG 1/40TH INT PERP NON CUM H

KEYCORP DEP SHS REP 1/40TH PERP PFD SER F USD25

KEYCORP DEP SHS REP 1/40TH NON CUM PFD SER E

Mizuho Financial Group, Inc.

Doximity (NYSE:DOCS) 在內部人士拋售後創下新的 52 周低點